FDA Consultants
(Voting)
Steven
Abramson, M.D.
Professor and Chairman,
Division of Rheumatology
Hospital for Joint
Diseases
Ralph B.
D’Agostino, Ph.D.
Professor
of Mathematics/Statistics
and
Public Health
Robert H.
Dworkin, Ph.D.
Professor of Anesthesiology
Neurology, Oncology and
Janet
Elashoff, Ph.D.
Director,
Division of Biostatistics
John T.
Farrar, M.D.
Senior
Scholar
Center for
Clinical Epidemiology and Biostatistics
Room 816,
Blockley Hall
PATIENT REPRESENTATIVE
Leona M.
Malone, L.C.S.W.
8D
Thomas
Fleming, Ph.D.
Professor
and Chairman
Department
of Biostatistics
Health
Sciences Bldg., Room F-600
Charles
H. Hennekens, M.D.
Visiting
Professor of Medicine &
Epidemiology
and Public Health
Steven
Nissen, M.D.
Medical Director,
Cardiovascular Coordinating Center
Department of Cardiovascular Medicine
Emil Paganini, M.D., FACP, FRCP
Section
Head, Dialysis
Steven L.
Shafer, M.D.
Professor of Anesthesia
VA
Alastair
J.J. Wood, M.D. (Meeting Chair)
Assistant Vice Chancellor
Professor of Medicine,
Professor of Pharmacology
Room 550
RRB
FDA CONSULTANTS
(NON-VOTING)
Byron
Cryer, M.D. (Speaker and Discussant)
Associate Professor of Medicine
Division of
Gastroenterology
Milton
Packer, M.D. (Speaker only)
Center for
Biostatistics and Clinical Sciences
NATIONAL INSTITUTES OF
HEALTH PARTICIPANTS
(VOTING)
Richard O.
Cannon III, M.D.
Clinical
Director, Division of Intramural Research
National
Institutes of Health
Building
10-CRC, Room 5-3330
Michael J.
Domanski, M.D.
Head,
Clinical Trials Group
National
Heart, Lung, and Blood Institute
National
Institutes of Health
GUEST SPEAKERS
(NON-VOTING)
Garret A.
FitzGerald, M.D.
Department
of Pharmacology
University
of
Room 153,
Johnson Pavilion
3620
Ernest
Hawk, M.D., M.P.H.
National
Institutes of Health
National Cancer
Institute
Director, Office of Centers
NCI/OD/NIH
Constantine
Lyketsos, M.D., M.H.S.
The Johns
The
Department
of Psychiatry
Bernard
Levin, M.D.
The
FDA PARTICIPANTS
CENTER FOR DRUG
EVALUATION AND RESEARCH
Jonca Bull,
M.D.
Director,
Office of Drug Evaluation V
Office of
New Drugs
David
Graham, M.D., M.P.H.
Medical
Officer
Office of
Pharmaceutical Science,
Office of
Pharmacoepidemiology and Statistical Science
Brian
Harvey, M.D.
Deputy
Director, Office of Drug Evaluation V
Office of New Drugs
Sharon
Hertz, M.D.
Deputy
Director, Division of Anti-Inflammatory,
Analgesic and Ophthalmologic Drug Products
John
Jenkins, M.D., F.C.C.P.
Director,
Office of New Drugs
Sandy
Kweder, M.D.
Deputy
Director, Office of New Drugs
Robert
O'Neil, Ph.D.
Director,
Office of Biostatistics
Joel
Schiffenbauer, M.D.
Medical Officer
Division of Anti-Inflammatory, Analgesic and
Ophthalmologic Drug Products
Paul Seligman, M.D.
Director, Office of Pharmacoepidemiology
and Statistical Science
Robert Temple, M.D.
Director, Office of Drug Evaluation
I
Anne Trontell, M.D., M.P.H.
Deputy Director, Office of Drug
Safety
Medical Officer
Division of Anti-Inflammatory, Analgesic and
Ophthalmologic
Drug Products
James Witter, M.D., Ph.D.
Medical Team Leader
Division
of Anti-Inflammatory, Analgesic and Ophthalmologic Drug Products